1PK0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dechra Pharmaceuticals PLC

Watchlist Manager

Watchlist

Price: 85.5 EUR

Market Cap: €4.9B

D	Dechra Pharmaceuticals PLC F:1PK0	UK
	Al Nahdi Medical Company SCJSC SAU:4164	SA
A	ABIOMED Inc XBER:AIO	US
I	Imperial Brands PLC XETRA:ITB	UK
	Nippon Sanso Holdings Corp F:NPX0	JP
	Engie SA F:GZF	FR
B	Brown-Forman Corp DUS:BF5B	US
V	VF Corp DUS:VFP	US
S	Swatch Group AG XBER:UHRN	CH
E	Exlservice Holdings Inc F:LHV	US
W	WesBanco Inc NASDAQ:WSBC	US
F	Frey SA F:943	FR

Profitability Summary

Dechra Pharmaceuticals PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

56%

Strong 3Y Average Gross Margin

56%

Declining Gross Margin

57% > 56%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

13% > 3%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-4%

Declining Net Margin

6% > -4%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

6% > 4%

Negative ROE

-4%

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.